Global Health Share Price

    NSE
    1327
    +23.70 (1.83%)
    MEDANTA • 14 Jul, 2025 | 03:29 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Global Health Stock Performance

    1W Return8.97
    1Y Return9.57
    Today's Low1296.6
    Prev. Close1,303.30
    Mkt Cap (Cr.)35,652.29
    1M Return11.92
    3Y Return0.00
    52-Week High1332.3
    Open1,304.90
    PE Ratio71.49
    6M Return29.60
    Today's High1332.3
    52-Week Low935.5
    Face Value2

    Global Health Company background

    Founded in: 2004
    Managing director: Naresh Kumar Trehan
    Global Health Limited (GHL) was incorporated as Global Health Private Limited on August 13, 2004 at New Delhi, India as a Private Limited Company. The Company got converted into a Public Limited Company and name of the Company was changed to Global Health Limited dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services.The Company was founded by Dr. Naresh Trehan, a worldrenowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multispeciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the Medanta brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. Company provide healthcare services in over 30 medical specialties and is engaged over 1700 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,823 installed beds to serve Indian and international patients.In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on publicprivate partnership at Patna.In 2019, it commenced operations of new hospital at Lucknow.In 2020, Patna hospitals outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022. The Company has taken inhouse facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.The Companys Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow Hospital further added 7 new OTs and have hired over 50 senior clinicians. Towards the end of FY 2023, Lucknow Hospital commissioned the Siemens Varian EDGE Radiation Oncology machine the first in North India as well as set up a dedicated eICU Command Centre to assist in remote critical care management. The Companys Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company introduced a new 300 bed hospital project in Indore. It started Medanta Labs in January 2023. During the year 202223, GHL Pharma was incorporated as a whollyowned subsidiary on June 29, 2022.The Company added 126 new beds, including 98 beds in Lucknow in March 2024 and 28 at the Patna hospital. Additionally, 4 new operating theatres were inaugurated at the Patna facility to address the increasing demand for surgical procedures and critical care. These expansions brought the total bed capacity to 2,823 across 5 hospitals as of March 31, 2024. Company also strengthened its clinical capabilities by onboarding over 150 new senior clinicians throughout the year. A comprehensive Oncology Care service program was launched at both Lucknow and Patna, featuring the operationalization of the Varian Edge Linear Accelerator (Linac) machine for radiation oncology. Further, eight new specialities were introduced at Patna, and five new specialities were launched at Lucknow.

    As of 14 Jul, 2025, Global Health share price is ₹1327.4. The stock opened at ₹1304.9 and had closed at ₹1303.3 the previous day. During today’s trading session, Global Health share price moved between ₹1,296.60 and ₹1,332.30, with an average price for the day of ₹1314.45. Over the last 52 weeks, the stock has recorded a low of ₹935.50 and a high of ₹1,332.30. In terms of performance, Global Health share price has increased by 28.6% over the past six months and has increased by 9.57% over the last year.

    Read More
    View details of Market Depth

    Global Health Fundamental

    Market Cap (in crs)

    35,652.29

    Face Value

    2

    Turnover (in lacs)

    4,387.18

    Key Metrics

    Qtr Change %
    New 52W High today
    4.5
    Dividend yield 1yr %
    0

    Global Health Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Global Health Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    931.25 Cr
    943.44 Cr
    956.56 Cr
    861.08 Cr
    808.63 Cr
    Global Health Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    3771.41 Cr
    3349.78 Cr
    2759.16 Cr
    2205.82 Cr
    1478.16 Cr
    1543.64 Cr
    Global Health Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    101.38 Cr
    142.86 Cr
    130.82 Cr
    106.26 Cr
    127.35 Cr
    Global Health Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    481.32 Cr
    478.06 Cr
    326.08 Cr
    196.2 Cr
    28.8 Cr
    36.35 Cr

    Global Health Result Highlights

    • Global Health Ltd reported a 12.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 14.2%.

    • Its expenses for the quarter were down by 11.6% QoQ and up 14.3% YoY.

    • The net profit decreased 10.9% QoQ and increased 26.0% YoY.

    • The earnings per share (EPS) of Global Health Ltd stood at 4.7 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Global Health

    Promoter
    33%
    Foreign Institutions
    11.8%
    Mutual Funds
    10.4%
    Domestic Institutions
    11.9%
    Public
    43.3%
    Promoter
    33%
    Foreign Institutions
    12.5%
    Mutual Funds
    9%
    Domestic Institutions
    10.5%
    Public
    44%
    Promoter
    33%
    Foreign Institutions
    12.2%
    Mutual Funds
    9.6%
    Domestic Institutions
    11.1%
    Public
    43.6%
    Promoter
    33%
    Foreign Institutions
    12.9%
    Mutual Funds
    9%
    Domestic Institutions
    10.6%
    Public
    43.4%
    Promoter
    33%
    Foreign Institutions
    12.1%
    Mutual Funds
    8.3%
    Domestic Institutions
    10.3%
    Public
    44.6%
    Promoter
    33%
    Foreign Institutions
    11.4%
    Mutual Funds
    8.6%
    Domestic Institutions
    11.1%
    Public
    44.4%

    Global Health Technical Analysis

    Moving Averages Analysis
    1327
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    1,287.00
    10Day EMA
    1,249.50
    12Day EMA
    1,239.80
    20Day EMA
    1,218.40
    26Day EMA
    1,211.40
    50Day EMA
    1,202.40
    100Day EMA
    1,189.70
    200Day EMA
    1,166.20
    5Day SMA
    1,285.90
    10Day SMA
    1,232.40
    20Day SMA
    1,189.80
    30Day SMA
    1,193.60
    50Day SMA
    1,198.10
    100Day SMA
    1,206.50
    150Day SMA
    1,166.00
    200Day SMA
    1,140.70
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    157330 Rs
    367543 Rs
    Week Rs
    344908 Rs
    1530281 Rs
    Month Rs
    219082 Rs
    587014 Rs
    1,318.77
    Pivot
    Resistance
    First Resistance
    1,340.93
    Second Resistance
    1,354.47
    Third Resistance
    1,376.63
    Support
    First Support
    1,305.23
    Second support
    1,283.07
    Third Support
    1,269.53
    Relative Strength Index
    75.69
    Money Flow Index
    93.63
    MACD
    28.45
    MACD Signal
    7.89
    Average True Range
    37.13
    Average Directional Index
    26.43
    Rate of Change (21)
    11.92
    Rate of Change (125)
    23.76
    Name
    Holding Percent
    KOTAK INDIA EQ CONTRA FUND
    2.93
    INVESCO INDIA AGGRESSIVE HYBRID FUND
    2.76
    CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO EMERGI
    1.43
    UTI-FLEXI CAP FUND
    1.18
    GOVERNMENT PENSION FUND GLOBAL
    3.3

    Global Health Latest News

    11 JUL 2025 | Friday

    Global Health Ltd - 543654 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    09 JUL 2025 | Wednesday

    Global Health Ltd - 543654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    27 JUN 2025 | Friday

    Global Health Ltd - 543654 - Closure of Trading Window

    View More

    Global Health Share Price FAQs

    Global Health share price is ₹1327 in NSE and ₹1328 in BSE as on 14/7/2025.

    Global Health share price in the past 1-year return was 9.57. The Global Health share hit a 1-year low of Rs. 935.5 and a 1-year high of Rs. 1332.3.

    The market cap of Global Health is Rs. 35652.29 Cr. as of 14/7/2025.

    The PE ratios of Global Health is 71.48 as of 14/7/2025.

    The PB ratios of Global Health is 10.18 as of 14/7/2025

    The Mutual Fund Shareholding in Global Health was 10.36% at the end of 14/7/2025.

    You can easily buy Global Health shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Global Health share price is ₹1332.3 and ₹935.5 as of 14/7/2025.

    Please be aware that Global Health stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.44
    -0.48 (-0.73%)
    134.11
    -1.17 (-0.86%)
    674.50
    -7.30 (-1.07%)
    2,581.30
    +22.60 (+0.88%)
    159.00
    -1.00 (-0.63%)
    382.30
    +0.65 (+0.17%)
    160.44
    +0.60 (+0.38%)
    270.60
    +7.25 (+2.75%)
    407.30
    -2.00 (-0.49%)
    402.55
    +5.70 (+1.44%)
    Top Gainers
    270.60
    +7.25 (+2.75%)
    3,404.70
    +43.10 (+1.28%)
    867.60
    +8.75 (+1.02%)
    244.22
    +2.46 (+1.02%)
    2,581.30
    +22.60 (+0.88%)
    Top Losers
    319.10
    -6.70 (-2.06%)
    1,576.70
    -25.80 (-1.61%)
    918.85
    -14.65 (-1.57%)
    254.25
    -4.05 (-1.57%)
    1,570.30
    -24.60 (-1.54%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -